Are We There Yet? The Telltale Trail of ctDNA in Rectal Cancer.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 41114665.
- Also identified by DOI 10.1158/1078-0432.CCR-25-2927.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
ctDNA has emerged as a noninvasive diagnostic and prognostic tool for colorectal cancer. The role of ctDNA in total neoadjuvant therapy and nonoperative management of locally advanced rectal cancer is uncertain. In this study, we discuss a ctDNA biomarker analysis of rectal cancer patients undergoing neoadjuvant therapy from the NOMINATE trial. See related article by Akiyoshi et al., p. 5188.
Medical subject headings
- Rectal Neoplasms
- Circulating Tumor DNA
- Biomarkers, Tumor